Tylidys 250 contains Lapatinib 250 mg, an oral targeted anti-cancer medicine used in the treatment of HER2-positive advanced or metastatic breast cancer. It works by blocking HER2 and EGFR proteins that promote the growth of cancer cells, helping to slow or stop tumor progression. It is commonly prescribed in combination with capecitabine or hormone therapy under the supervision of an oncologist.